Dermatology · Pasadena, TX
NPI
1134549140
Since 2014
Specialty
Dermatology
Code 207N00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
3901 Woodlawn Ave
Pasadena, TX, 77504
Phone (713) 946-2666
Medicare paid, 2024
$113K
3,021 services
Medicare patients, 2024
508
Average age 74
Drug cost, 2024
$942K
3,196 prescriptions
Company payments, 2025
$3,010
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by William E Tausend was code 17003 (destruction skin lesion), 785 times for 135 patients. In total William E Tausend billed 3,021 services in 50 codes, and Medicare paid $113K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-07-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 785 | 135 | $4.43 | $3,481 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 488 | 76 | $0.72 | $353 |
| 99214 Office E&M - Established | Office | 276 | 198 | $83.51 | $23K |
| 17110 Destruction Skin Lesion | Office | 261 | 209 | $69.26 | $18K |
| 17000 Destruction Skin Lesion | Office | 234 | 177 | $30.62 | $7,166 |
| 99213 Office E&M - Established | Office | 172 | 144 | $62.63 | $11K |
| 96372 Injection Administration | Office | 126 | 94 | $9.62 | $1,212 |
| 11102 Skin Biopsy | Office | 109 | 93 | $54.96 | $5,991 |
| 99203 Office E&M - New | Office | 73 | 73 | $69.93 | $5,105 |
| 17111 Destruction Skin Lesion | Office | 73 | 57 | $87.54 | $6,391 |
| 11900 Skin | Office | 57 | 39 | $33.80 | $1,927 |
| 11103 Skin Biopsy | Office | 45 | 26 | $33.90 | $1,526 |
| 17004 Destruction Skin Lesion | Office | 42 | 32 | $111.39 | $4,679 |
| 11301 Removal or Shaving of Skin Growth | Office | 23 | 22 | $71.49 | $1,644 |
| 17261 Destruction Skin Lesion | Office | 23 | 17 | $92.65 | $2,131 |
By year: 2022 $125K for 2,941 services; 2023 $132K for 3,164 services; 2024 $113K for 3,021 services.
Medicare prescription drug claims, 2024
In 2024, the drug William E Tausend prescribed most often to Medicare patients was Clobetasol Propionate, with 587 prescriptions and refills. In total William E Tausend wrote 3,196 Medicare prescriptions that cost $942K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clobetasol Propionate Generic | 587 | 594 | 324 | $21K |
| Triamcinolone Acetonide Generic | 472 | 534 | 295 | $7,458 |
| Alclometasone Dipropionate Generic | 276 | 277 | 164 | $18K |
| Mupirocin Generic | 203 | 204 | 148 | $1,729 |
| Doxycycline Monohydrate Generic | 168 | 205 | 83 | $5,753 |
| Ketoconazole Generic | 153 | 158 | 82 | $4,411 |
| Ammonium Lactate Generic | 137 | 146 | 83 | $4,115 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 123 | 124 | 61 | $6,612 |
| Fluorouracil Generic | 122 | 125 | 97 | $11K |
| Mometasone Furoate Generic | 70 | 73 | 38 | $1,990 |
| Doxepin Hcl Generic | 69 | 117 | 30 | $1,126 |
| Hydroxyzine Hcl Generic | 60 | 61 | 36 | $621 |
| Metronidazole Generic | 57 | 60 | 34 | $4,051 |
| Ciclopirox Generic | 54 | 64 | 25 | $1,813 |
| Clindamycin Phosphate Generic | 50 | 51 | 33 | $1,339 |
Brand drugs: 96 claims; generic drugs: 3,100 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid William E Tausend $3,010 ($3,010 in general payments such as food, travel and fees) from 18 companies. The largest payer was Janssen Biotech, Inc. with $662.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 26 | $662 |
| Abbvie Inc. ABBV | 25 | $472 |
| Lilly USA, LLC LLY | 12 | $335 |
| Genzyme Corporation SNY | 11 | $329 |
| Novartis Pharmaceuticals Corporation NVS | 12 | $244 |
| Mayne Pharma Commercial LLC | 18 | $189 |
| Amgen Inc. AMGN | 10 | $188 |
| Organon LLC OGN | 8 | $180 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 5 | $85.54 |
| UCB, Inc. UCB.BR | 2 | $67.72 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.